Trials / Completed
CompletedNCT01294969
Patient Perception Study for AL-4943A
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate patient perceptions of Al-4943 in subjects with allergic conjunctivitis previously treated with a topical ocular anti-allergy leukotriene-release inhibitor medication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AL-4943A | Once daily topical ocular allergy medication used for 7 days |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2011-02-14
- Last updated
- 2016-12-16
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01294969. Inclusion in this directory is not an endorsement.